scholarly article | Q13442814 |
P356 | DOI | 10.4049/JIMMUNOL.174.6.3143 |
P8608 | Fatcat ID | release_u7apifms6vgrxcirlv2r737th4 |
P698 | PubMed publication ID | 15749840 |
P5875 | ResearchGate publication ID | 7984024 |
P50 | author | Jakob Nilsson | Q55207977 |
P2093 | author name string | Rui Zhang | |
Jan Andersson | |||
Norah J Shire | |||
Claire A Chougnet | |||
Gene M Shearer | |||
Adriano Boasso | |||
Stefan Lindback | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | patient | Q181600 |
viral load | Q2528140 | ||
P304 | page(s) | 3143-3147 | |
P577 | publication date | 2005-03-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients | |
P478 | volume | 174 |
Q57235889 | A Novel 8-Color Flow Cytometry Panel to Study Activation, Maturation and Senescence of CD4 and CD8 T Lymphocytes in HIV-Infected Individuals at Different Stages of Disease |
Q36887125 | A decade of AIRE. |
Q36535798 | A dendrite in every pie: myeloid dendritic cells in HIV and SIV infection. |
Q35862319 | A randomized case-control study of dynamic changes in peripheral blood Th17/Treg cell balance and interleukin-17 levels in highly active antiretroviral-treated HIV type 1/AIDS patients |
Q34441167 | Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection |
Q45362664 | Altered phenotype of regulatory T cells associated with lack of human immunodeficiency virus (HIV)-1-specific suppressive function. |
Q41629369 | Analysis of mRNA expression for genes associated with regulatory T lymphocytes (CD25, FoxP3, CTLA4, and IDO) after experimental infection with bovine viral diarrhea virus of low or high virulence in beef calves |
Q34534197 | Analysis of suppressor and non-suppressor FOXP3+ T cells in HIV-1-infected patients |
Q92316582 | Angiogenesis, Lymphangiogenesis, and the Immune Response in South African Preeclamptic Women Receiving HAART |
Q27342233 | Attenuation of pathogenic immune responses during infection with human and simian immunodeficiency virus (HIV/SIV) by the tetracycline derivative minocycline |
Q59341392 | B-cell and T-cell activation in South African HIV-1-positive non-Hodgkin's lymphoma patients |
Q37195654 | CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection |
Q37401696 | CD137 costimulation of CD8+ T cells confers resistance to suppression by virus-induced regulatory T cells |
Q35861968 | CD4 T Cell Depletion Substantially Augments the Rescue Potential of PD-L1 Blockade for Deeply Exhausted CD8 T Cells |
Q34841938 | CD4 T Cells Mediate Both Positive and Negative Regulation of the Immune Response to HIV Infection: Complex Role of T Follicular Helper Cells and Regulatory T Cells in Pathogenesis |
Q36185114 | CD4(+) T Follicular Helper and IgA(+) B Cell Numbers in Gut Biopsies from HIV-Infected Subjects on Antiretroviral Therapy Are Similar to HIV-Uninfected Individuals |
Q28751971 | CD4+ T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individuals |
Q36827240 | CD4+ T cells develop antiretroviral cytotoxic activity in the absence of regulatory T cells and CD8+ T cells |
Q57609524 | CD4+ and CD8+ Regulatory T Cells (Tregs) are Elevated and Display an Active Phenotype in Patients with Chronic HCV Mono-Infection and HIV/HCV Co-Infection |
Q37515698 | CD4+CD25+ T regulatory cells activated during feline immunodeficiency virus infection convert T helper cells into functional suppressors through a membrane-bound TGFβ / GARP-mediated mechanism |
Q43225104 | CD4+CD25+ regulatory T cells are infected and activated during acute FIV infection |
Q33911819 | CD8+ T-cell dysfunction due to cytolytic granule deficiency in persistent Friend retrovirus infection |
Q37543246 | CTL quality and the control of human retroviral infections |
Q35848881 | CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques |
Q50635555 | Cellular and humoral immune responses to chimeric EGFP-pseudocapsids derived from the mouse polyomavirus after their intranasal administration. |
Q33996628 | Characterisation of regulatory T cells in nasal associated lymphoid tissue in children: relationships with pneumococcal colonization. |
Q36938152 | Chemokine and cytokine mediated loss of regulatory T cells in lymph nodes during pathogenic simian immunodeficiency virus infection |
Q33613674 | Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation |
Q36510689 | Chronic innate immune activation as a cause of HIV-1 immunopathogenesis |
Q42157400 | Chronically HIV-1 Infected Patients Exhibit Low Frequencies of CD25+ Regulatory T Cells. |
Q34259974 | Circulating Type-1 Anti-Tumor CD4(+) T Cells are Preferentially Pro-Apoptotic in Cancer Patients. |
Q43699872 | Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques |
Q35067219 | Combining regulatory T cell depletion and inhibitory receptor blockade improves reactivation of exhausted virus-specific CD8+ T cells and efficiently reduces chronic retroviral loads |
Q37197377 | Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory t cells in the granulomatous lesions |
Q34487847 | Comprehensive Analysis of Frequency and Phenotype of T Regulatory Cells in HIV Infection: CD39 Expression of FoxP3+T Regulatory Cells Correlates with Progressive Disease |
Q33874652 | Dendritic cell-based human immunodeficiency virus vaccine |
Q91967406 | Differential Dynamics of Regulatory T-Cell and Th17 Cell Balance in Mesenteric Lymph Nodes and Blood following Early Antiretroviral Initiation during Acute Simian Immunodeficiency Virus Infection |
Q34944988 | Distinct expression profiles of TGF-beta1 signaling mediators in pathogenic SIVmac and non-pathogenic SIVagm infections |
Q27003380 | Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model |
Q34091313 | Dynamics of regulatory T-cells during pregnancy: effect of HIV infection and correlations with other immune parameters |
Q37706839 | Early and long-lasting alteration of effector CD45RA(-)Foxp3(high) regulatory T-cell homeostasis during HIV infection |
Q35069126 | Early short-term antiretroviral therapy is associated with a reduced prevalence of CD8(+)FoxP3(+) T cells in simian immunodeficiency virus-infected controller rhesus macaques |
Q56994404 | Elite control of HIV infection: implications for vaccine design |
Q36173997 | Endogenous TGF-beta activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4+CD25- T cells |
Q54942553 | Epigenetic Modulation of CD8⁺ T Cell Function in Lentivirus Infections: A Review. |
Q34699537 | Expression of a broad array of negative costimulatory molecules and Blimp-1 in T cells following priming by HIV-1 pulsed dendritic cells |
Q43515102 | FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection |
Q53556653 | FOXP3 gene expression in a tuberculosis case contact study. |
Q37620568 | Fallen angels or risen apes? A tale of the intricate complexities of imbalanced immune responses in the pathogenesis and progression of immune-mediated and viral cancers |
Q36192967 | Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection. |
Q35566145 | FoxP3 enhances HIV-1 gene expression by modulating NFkappaB occupancy at the long terminal repeat in human T cells |
Q36315222 | FoxP3+ CD25+ CD8+ T-cell induction during primary simian immunodeficiency virus infection in cynomolgus macaques correlates with low CD4+ T-cell activation and high viral load |
Q36915916 | FoxP3+CD4+ regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2-/-gammaC-/- mice in vivo |
Q38572329 | Foxp3 and Treg cells in HIV-1 infection and immuno-pathogenesis |
Q42870566 | Frequencies of FoxP3+ naive T cells are related to both viral load and naive T cell proliferation responses in HIV disease. |
Q28741958 | Frequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapy |
Q34574856 | Functional characterization of HLA-G⁺ regulatory T cells in HIV-1 infection |
Q31079257 | GLI2 regulates TGF-β1 in human CD4+ T cells: implications in cancer and HIV pathogenesis |
Q21146758 | Generalized immune activation as a direct result of activated CD4+ T cell killing |
Q34007172 | Good cell, bad cell: flow cytometry reveals T-cell subsets important in HIV disease |
Q44134757 | HAART reduces death ligand but not death receptors in lymphoid tissue of HIV-infected patients and simian immunodeficiency virus-infected macaques. |
Q86268973 | HIV immunodynamics and multiple sclerosis |
Q35751070 | HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells |
Q37104632 | HIV-1 binding to CD4 on CD4+CD25+ regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppression |
Q89547831 | HIV-1 elite controllers present a high frequency of activated regulatory T and Th17 cells |
Q34422185 | HIV-1 shedding from the female genital tract is associated with increased Th1 cytokines/chemokines that maintain tissue homeostasis and proportions of CD8+FOXP3+ T cells |
Q35848896 | HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. |
Q33359564 | HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation |
Q42432007 | HIV-specific TGF-beta-positive CD4+ T cells do not express regulatory surface markers and are regulated by CTLA-4. |
Q35372836 | HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection |
Q35131194 | Helminths and HIV infection: epidemiological observations on immunological hypotheses |
Q83003156 | High frequency and proliferation of CD4+ FOXP3+ Treg in HIV-1-infected patients with low CD4 counts |
Q30426654 | High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088) |
Q36871006 | Highly active antiretroviral therapy reduces pulmonary IL-8 in HIV-positive women smokers |
Q26995345 | Homeostasis and function of regulatory T cells in HIV/SIV infection |
Q37452486 | Human regulatory T cells are targets for human immunodeficiency Virus (HIV) infection, and their susceptibility differs depending on the HIV type 1 strain |
Q34112781 | IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery. |
Q35784621 | IL-23 in infections, inflammation, autoimmunity and cancer: possible role in HIV-1 and AIDS |
Q35826138 | Immune correlates of herpes zoster in HIV-infected children and youth |
Q40377124 | Immune deficiency in HIV-1 infection: novel therapeutic approaches targeting innate and adaptive responses |
Q33992829 | Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it? |
Q34984010 | Immune exhaustion occurs concomitantly with immune activation and decrease in regulatory T cells in viremic chronically HIV-1-infected patients |
Q36624200 | Immune reconstitution disease associated with parasitic infections following antiretroviral treatment |
Q27687272 | Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs. |
Q43608840 | Immunogenic and tolerogenic signatures in human immunodeficiency virus (HIV)-infected controllers compared with progressors and a conversion strategy of virus control |
Q56900652 | Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis |
Q36313789 | Impaired expression of perforin and granulysin in CD8+ T cells at the site of infection in human chronic pulmonary tuberculosis |
Q33889113 | In vivo depletion of CD4(+)CD25(hi) regulatory T cells is associated with improved antiviral responses in cats chronically infected with feline immunodeficiency virus |
Q34963393 | Incomplete normalization of regulatory t-cell frequency in the gut mucosa of Colombian HIV-infected patients receiving long-term antiretroviral treatment |
Q46247986 | Increased Th17 functions are accompanied by Tregs activities in lupoid leishmaniasis |
Q27482577 | Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection |
Q35363011 | Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers |
Q28748867 | Increased sensitivity of CD4+ T-effector cells to CD4+CD25+ Treg suppression compensates for reduced Treg number in asymptomatic HIV-1 infection |
Q34655953 | Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. |
Q36228356 | Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens |
Q34571341 | Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection |
Q37123309 | Infection with feline immunodeficiency virus directly activates CD4+ CD25+ T regulatory cells |
Q35848218 | Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis |
Q37006795 | Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infection |
Q33883704 | Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans |
Q42108150 | Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population. |
Q42225256 | Is Graves' disease a primary immunodeficiency? New immunological perspectives on an endocrine disease |
Q36696881 | Lentivirus-induced immune dysregulation |
Q36868157 | Longitudinal evaluation of regulatory T-cell dynamics on HIV-infected individuals during the first 2 years of therapy |
Q40227012 | Microbial infection-induced expansion of effector T cells overcomes the suppressive effects of regulatory T cells via an IL-2 deprivation mechanism |
Q34980150 | Modulating DNA methylation in activated CD8+ T cells inhibits regulatory T cell-induced binding of Foxp3 to the CD8+ T Cell IL-2 promoter |
Q38091548 | Molecular signatures of T-cell inhibition in HIV-1 infection |
Q33681946 | Mucosal T-cell responses to HIV: responding at the front lines |
Q37137068 | Mucosal immunity to HIV: a review of recent literature |
Q36634172 | Multiple roles for chemokines in the pathogenesis of SIV infection |
Q34149784 | Mycobacterium tuberculosis modulates the gene interactions to activate the HIV replication and faster disease progression in a co-infected host |
Q36883762 | Myeloid dendritic cells isolated from tissues of SIV-infected Rhesus macaques promote the induction of regulatory T cells |
Q36563554 | Natural regulatory T cells and parasites: a common quest for host homeostasis |
Q36423940 | Natural regulatory T cells and persistent viral infection |
Q36078051 | Natural regulatory T cells in infectious disease |
Q37141166 | Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration |
Q26777036 | New Insights about Treg and Th17 Cells in HIV Infection and Disease Progression |
Q59350268 | Nonhuman primate models of human viral infections |
Q51980648 | Optimization of in vitro expansion of macaque CD4 T cells using anti-CD3 and co-stimulation for autotransfusion therapy. |
Q37408390 | PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes |
Q38114910 | Pathobiology of HIV/SIV-associated changes in secondary lymphoid tissues |
Q36274922 | Perils at mucosal front lines for HIV and SIV and their hosts |
Q46266432 | Peripheral CD4 loss of regulatory T cells is associated with persistent viraemia in chronic HIV infection |
Q38061723 | Persistent infectious diseases say - IDO. Role of indoleamine-2,3-dioxygenase in disease pathogenesis and implications for therapy |
Q40616630 | Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice. |
Q35162498 | Polymorphisms in the IFNγ, IL-10, and TGFβ genes may be associated with HIV-1 infection |
Q34600441 | Poor immune reconstitution in HIV-infected patients associates with high percentage of regulatory CD4+ T cells |
Q36845770 | Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation. |
Q44816481 | Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease. |
Q92903815 | Proliferative memory SAMHD1low CD4+ T cells harbour high levels of HIV-1 with compartmentalized viral populations |
Q35885111 | Protective HIV-specific CD8+ T cells evade Treg cell suppression |
Q45057875 | Regulation of Th-1 T cell-dominated immunity to Neisseria meningitidis within the human mucosa |
Q52715799 | Regulatory T Cells As Potential Targets for HIV Cure Research. |
Q36102001 | Regulatory T Cells Modulate DNA Vaccine Immunogenicity at Early Time via Functional CD4(+) T Cells and Antigen Duration |
Q42667085 | Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression |
Q37101255 | Regulatory T cells and human disease |
Q36975739 | Regulatory T cells and infection: a dangerous necessity |
Q37695072 | Regulatory T cells and the risk of CMV end-organ disease in patients with AIDS. |
Q35029947 | Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism |
Q37550813 | Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of pneumocystis pneumonia |
Q33611828 | Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets. |
Q37139998 | Regulatory T cells in HIV infection: who's suppressing what? |
Q81355901 | Regulatory T cells in HIV infection: who's suppressing what? |
Q45390515 | Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy |
Q37961175 | Regulatory T cells in infection |
Q49979151 | Regulatory T cells in retroviral infections |
Q34251387 | Regulatory T cells in the pathogenesis and healing of chronic human dermal leishmaniasis caused by Leishmania (Viannia) species |
Q36563550 | Regulatory T cells in virus infections |
Q33776491 | Regulatory T cells inhibit T cell proliferation and decrease demyelination in mice chronically infected with a coronavirus |
Q55451096 | Regulatory T cells suppress virus-specific antibody responses to Friend retrovirus infection. |
Q95363128 | Regulatory T cells: the ultimate HIV reservoir? |
Q36315049 | Regulatory T-cell markers, indoleamine 2,3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection |
Q27022973 | Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression |
Q36304297 | Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy |
Q33640197 | Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy |
Q33737475 | Role of Foxp3-positive regulatory T cells during infection |
Q36162862 | Role of endogenous and induced regulatory T cells during infections |
Q33862584 | Role played by CD4+FOXP3+ regulatory T Cells in suppression of host responses to Haemophilus ducreyi during experimental infection of human volunteers |
Q35623739 | Semen of HIV-1-infected individuals: local shedding of herpesviruses and reprogrammed cytokine network |
Q36315704 | Severe depletion of CD4+ CD25+ regulatory T cells from the intestinal lamina propria but not peripheral blood or lymph nodes during acute simian immunodeficiency virus infection |
Q36229304 | Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis |
Q35197399 | Structural variants of IFNα preferentially promote antiviral functions |
Q36415780 | Studies of HIV-associated immune responses in lymphoid compartments |
Q35652583 | Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals |
Q42273692 | Suppression of NK cells and regulatory T lymphocytes in cats naturally infected with feline infectious peritonitis virus |
Q64079589 | T Cell Therapy Targeted on HLA-A02 Restricted HIV Antigen Epitopes: An Open Label Cellular Therapy Trial Using CD8+ T Cell |
Q34510458 | T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy. |
Q37789345 | T cell immunity in acute HIV-1 infection. |
Q33807523 | T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines |
Q35459820 | T regulatory cells: aid or hindrance in the clearance of disease? |
Q45365327 | T-regulatory cells infected with feline immunodeficiency virus up-regulate programmed death-1 (PD-1). |
Q33519047 | TGF-beta and IL-10 production by HIV-specific CD8+ T cells is regulated by CTLA-4 signaling on CD4+ T cells |
Q36625426 | The Immune Fulcrum: Regulatory T Cells Tip the Balance Between Pro- and Anti-inflammatory Outcomes upon Infection |
Q38675915 | The Janus-faced nature of IDO1 in infectious diseases: challenges and therapeutic opportunities. |
Q97883485 | The Role of Immunomodulatory Receptors in the Pathogenesis of HIV Infection: A Therapeutic Opportunity for HIV Cure? |
Q45783074 | The Role of Transforming Growth Factor Beta-1 in the Progression of HIV/AIDS and Development of Non-AIDS-Defining Fibrotic Disorders |
Q82644038 | The decrease of regulatory T cells correlates with excessive activation and apoptosis of CD8+ T cells in HIV-1-infected typical progressors, but not in long-term non-progressors |
Q37204158 | The majority of HIV type 1 DNA in circulating CD4+ T lymphocytes is present in non-gut-homing resting memory CD4+ T cells |
Q34740235 | The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study |
Q36242461 | The role of CD4+CD25+ regulatory T cells in viral infections |
Q57170667 | The role of follicular helper CD4 T cells in the development of HIV-1 specific broadly neutralizing antibody responses |
Q36535760 | The role of virus-induced regulatory T cells in immunopathology |
Q34573008 | Transient depletion of regulatory T cells in transgenic mice reactivates virus-specific CD8+ T cells and reduces chronic retroviral set points |
Q35792962 | Transient regulatory T-cells: a state attained by all activated human T-cells. |
Q37632479 | Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. |
Q37295142 | Treatment with anti-FasL antibody preserves memory lymphocytes and virus-specific cellular immunity in macaques challenged with simian immunodeficiency virus |
Q26822874 | Tregs in infection and vaccinology: heroes or traitors? |
Q83350829 | UBD, a downstream element of FOXP3, allows the identification of LGALS3, a new marker of human regulatory T cells |
Q37931979 | cAMP during HIV infection: friend or foe? |
Q36434375 | p38 Mitogen-activated protein kinase/signal transducer and activator of transcription-3 pathway signaling regulates expression of inhibitory molecules in T cells activated by HIV-1-exposed dendritic cells |
Search more.